Related Experiment Video
Updated: May 17, 2025
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Global Hemostasis Testing in Chronic Kidney Disease-Are They Better Predictors of Bleeding and Thrombosis Risk?
Hui Yin Lim1,2,3, Eng Soo Yap4,5, Prahlad Ho1,2,3
1Northern Clinical Diagnostics and Thrombovascular Research (NECTAR), Northern Health, Epping, Victoria, Australia.
Insights
Chronic kidney disease (CKD) alters blood clotting, increasing bleeding risk. Global hemostatic assays offer a better assessment of bleeding and clotting in CKD patients than standard tests.
Area of Science:
- Nephrology
- Hematology
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) impacts over 10% of the global population.
- CKD significantly elevates risks for cardiovascular disease and bleeding complications.
- Hemostasis in CKD is complex, involving coagulation, platelets, and the vessel wall.
Purpose of the Study:
- To critically review studies using global coagulation assays for hemostasis evaluation in CKD patients.
- To assess the utility of these assays in predicting clinical outcomes like bleeding and thrombosis.
- To highlight the limitations of conventional tests in CKD hemostasis assessment.
Main Methods:
- Systematic review and critical appraisal of published literature.
- Focus on studies employing global hemostatic assays (e.g., thrombin generation, fibrin generation).
- Analysis of associations between assay results and clinical outcomes in CKD.
Main Results:
- Conventional coagulation tests and renal function do not fully capture hemostatic alterations in CKD.
- Global hemostatic assays provide a comprehensive assessment of hemostasis, including interactions between procoagulants, anticoagulants, platelets, and fibrinolysis.
- These assays show promise in better reflecting bleeding and/or thrombosis risk in CKD patients.
Conclusions:
- Global hemostatic assays offer a more thorough evaluation of hemostasis in CKD compared to traditional methods.
- Improved hemostasis assessment is crucial for optimal patient management and risk stratification in CKD.
- Further research validating global assays for clinical decision-making in CKD is warranted.
Abstract:
Chronic kidney disease (CKD) affects over 10% of the global population and significantly increases the risk of cardiovascular disease as well as arising bleeding. There are alterations in hemostasis, which are multifactorial, involving complex interactions between coagulation, platelets, and the vessel wall. Hemostasis evaluation in CKD is critical for the optimal management of patients. However, conventional coagulation testing and renal function do not fully reflect the hemostatic alterations and do not adequately represent the risk of bleeding and/or thrombosis in patients with CKD. Global hemostatic assays, including thrombin and fibrin generation assays, provide a more wholesome assessment of the process, including the interaction between procoagulants, anticoagulants, platelets, and fibrinolysis. This review critically appraises published studies reporting the use of global coagulation assays to evaluate hemostasis in patients with CKD, as well as associated clinical outcomes.
More Related Videos
07:48Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock
Published on: October 28, 2022
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...